Multiple drug-resistant HBV mutation may contribute to poor response of adefovir + entecavir in entecavir-resistant patients.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of infection in developing countries"
DOI: 10.3855/jidc.12643
Abstract: INTRODUCTION Adefovir plus entecavir (ADV+ETV) rescue therapy in ETV-resistant patients with chronic hepatitis B virus (HBV) infection is suboptimal in some patients. This study aims to elucidate the evolutionary characteristics of drug-resistant HBV mutants and… read more here.
Keywords: entecavir; etv resistant; hbv; drug ... See more keywords